Cargando…
The brain‐penetrant ATM inhibitor, AZD1390, promotes axon regeneration and functional recovery in preclinical models of spinal cord injury
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9274214/ https://www.ncbi.nlm.nih.gov/pubmed/35818848 http://dx.doi.org/10.1002/ctm2.962 |
_version_ | 1784745259328077824 |
---|---|
author | Ahmed, Zubair Tuxworth, Richard I. |
author_facet | Ahmed, Zubair Tuxworth, Richard I. |
author_sort | Ahmed, Zubair |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9274214 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92742142022-07-15 The brain‐penetrant ATM inhibitor, AZD1390, promotes axon regeneration and functional recovery in preclinical models of spinal cord injury Ahmed, Zubair Tuxworth, Richard I. Clin Transl Med Letter to Editor John Wiley and Sons Inc. 2022-07-12 /pmc/articles/PMC9274214/ /pubmed/35818848 http://dx.doi.org/10.1002/ctm2.962 Text en © 2022 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Letter to Editor Ahmed, Zubair Tuxworth, Richard I. The brain‐penetrant ATM inhibitor, AZD1390, promotes axon regeneration and functional recovery in preclinical models of spinal cord injury |
title | The brain‐penetrant ATM inhibitor, AZD1390, promotes axon regeneration and functional recovery in preclinical models of spinal cord injury |
title_full | The brain‐penetrant ATM inhibitor, AZD1390, promotes axon regeneration and functional recovery in preclinical models of spinal cord injury |
title_fullStr | The brain‐penetrant ATM inhibitor, AZD1390, promotes axon regeneration and functional recovery in preclinical models of spinal cord injury |
title_full_unstemmed | The brain‐penetrant ATM inhibitor, AZD1390, promotes axon regeneration and functional recovery in preclinical models of spinal cord injury |
title_short | The brain‐penetrant ATM inhibitor, AZD1390, promotes axon regeneration and functional recovery in preclinical models of spinal cord injury |
title_sort | brain‐penetrant atm inhibitor, azd1390, promotes axon regeneration and functional recovery in preclinical models of spinal cord injury |
topic | Letter to Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9274214/ https://www.ncbi.nlm.nih.gov/pubmed/35818848 http://dx.doi.org/10.1002/ctm2.962 |
work_keys_str_mv | AT ahmedzubair thebrainpenetrantatminhibitorazd1390promotesaxonregenerationandfunctionalrecoveryinpreclinicalmodelsofspinalcordinjury AT tuxworthrichardi thebrainpenetrantatminhibitorazd1390promotesaxonregenerationandfunctionalrecoveryinpreclinicalmodelsofspinalcordinjury AT ahmedzubair brainpenetrantatminhibitorazd1390promotesaxonregenerationandfunctionalrecoveryinpreclinicalmodelsofspinalcordinjury AT tuxworthrichardi brainpenetrantatminhibitorazd1390promotesaxonregenerationandfunctionalrecoveryinpreclinicalmodelsofspinalcordinjury |